Market Overview

Benzinga's Top Initiations

Share:
Benzinga's Top Initiations
Related ISRG
Goldman Remains Constructive on MedTech, Sees 'New Opportunities' Amid Selloff
Market Update: Wednesday's Mid-Day Movers: U.S., Asian Markets Slow; Apple, Microsoft, Chipotle, IBM And More
The Zacks Analyst Blog Highlights: Google, Gilead Sciences, Regeneron Pharmaceuticals, Intuitive Surgical and Amazon.com (Zacks)
Related BCRX
2 Biotech Stocks That Could Skyrocket In The Next 12 Months
Robert Ingram Named to BioCryst's Board of Directors
Investors' Radars Failed to Catch BioCryst Pharmaceuticals (BCRX), Has Yours? (Zacks)

Analysts at ISI Group initiated coverage on shares of Intuitive Surgical (NASDAQ: ISRG) with a “strong buy” rating. The target price for Intuitive Surgical is set to $50. Intuitive Surgical's shares closed at $430.14 on Friday.

Analysts at Roth Capital initiated coverage on shares of BioCryst Pharmaceuticals (NASDAQ: BCRX) with a “buy” rating. The target price for BioCryst Pharmaceuticals is set to $18. BioCryst Pharmaceuticals' shares closed at $10.80 on Friday.

Morgan Stanley initiated coverage on shares of ARAMARK Holdings (NYSE: ARMK) with an “overweight” rating. The target price for ARAMARK Holdings is set to $29. ARAMARK's shares closed at $24.51 on Friday.

Deutsche Bank initiated coverage on shares of Hilton Worldwide (NYSE: HLT) with a “buy” rating. The target price for Hilton Worldwide is set to $27. Hilton Worldwide's shares closed at $22.25 on Friday.

Latest Ratings for ISRG

DateFirmActionFromTo
Jul 2015Canaccord GenuityUpgradesBuy
Jul 2015BarclaysMaintainsOverweight
Jul 2015Morgan StanleyDowngradesEqual-weightUnderweight

View More Analyst Ratings for ISRG
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings

 

Related Articles (BCRX + ARMK)

Get Benzinga's Newsletters